DRI Healthcare Trust Announces Voting Results of AGM

TORONTO, May 12, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 12, 2023. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March 29, […]

DRI Healthcare Trust Reports First Quarter 2023 Results

fallback

– Robust royalty transaction activity showcases ability to execute on attractive deals – – Continued strong performance of existing assets and financial results – TORONTO, May 11, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its financial results for the quarter ended March 31, 2023. The Trust’s first […]

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

TORONTO, May 10, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust intends to participate in the following investor conferences in spring 2023: RBC Global Healthcare Conference Date: May 17, 2023 Presentation time: 2:30 pm ET City: New York, New York UBS Spring Biotech Conference Date: May […]

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 12, 2023

sparkle bg

TORONTO, April 27, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it will hold a conference call to discuss its first quarter financial results on Friday, May 12, 2023, at 8:00 a.m. ET. The Trust will report its financial results on Thursday, May 11, 2023, after […]

DRI Healthcare Trust Announces Sale of its TZIELD™ Royalty Interest to Sanofi for US$210 Million and Announces a US$20 Million Special Cash Distribution to Unitholders

– Transaction will allow DHT to redeploy capital into new deals generating compounding returns for unitholders – TORONTO, April 27, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“the Trust”) announces that its wholly-owned subsidiary has sold its royalty interest and milestone payment obligations in the worldwide sales of TZIELD™ to a subsidiary […]

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELD™ (teplizumab-mzwv) and Updates Long-Term Cash Receipts Outlook

AdobeStock 256444328

– Transaction adds a ground-breaking type 1 diabetes therapy to DRI’s expanding portfolio – – Excluding any new transactions, DRI now expects 2030 cash receipts to be at least as high as 2022 cash receipts – – Extends DRI’s overall portfolio duration to over 10 years – TORONTO, March 8, 2023 /CNW/ – DRI Healthcare […]

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2022 Results

sparkle bg

– 2022 deployment of US$281 million continues to validate growth strategy – – Continued strong performance of existing assets and financial results – TORONTO, March 1, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2022. […]

DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased Deployment Target

fallback

– Provides additional capital to fund biopharmaceutical research, driving value for DRI’s unitholders and partners –  TORONTO, Feb. 8, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it has completed a private placement of US$95 million of preferred securities (the “Private Placement”) to an investor group that […]